Pui, Ching-Hon
Article History
Received: 20 October 2019
Accepted: 14 February 2020
First Online: 19 October 2020
Compliance with ethics guidelines
: Ching-Hon Pui declares that he is on the scientific advisory board for Adaptive Biotechnologies, Inc. and received honoraria from Amgen, Servier and Erytech. This manuscript is a review article and does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.